Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Activartis Biotech GmbH
DescriptionDendritic cell-based cancer immunotherapy
Molecular Target
Mechanism of ActionVaccine
Therapeutic ModalityActive immunotherapy
Latest Stage of DevelopmentPhase II
Standard IndicationBrain cancer
Indication DetailsTreat glioblastoma multiforme (GBM); Treat glioma; Treat malignant glioma
Regulatory Designation U.S. - Orphan Drug (Treat malignant glioma);
EU - Orphan Drug (Treat glioma)

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today